Stereoselective disposition of flupentixol: influence on steady-state plasma concentrations in schizophrenic patients. 1987

A E Balant-Gorgia, and L P Balant, and M Gex-Fabry, and C Genet
Department of Psychiatry, University of Geneva, Switzerland.

Steady-state plasma concentrations of cis(Z)-flupentixol (active principle) and trans(E)-flupentixol (inactive) were measured in 41 patients at least on one occasion. Results indicate that concentrations of the trans-isomer are significatively higher. This demonstrates that the two isomers are not handled in the same way by the organism. This may be relevant if plasma level monitoring is performed using non-specific analytical methods.

UI MeSH Term Description Entries
D007536 Isomerism The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Isomerisms
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005475 Flupenthixol A thioxanthene neuroleptic that, unlike CHLORPROMAZINE, is claimed to have CNS-activating properties. It is used in the treatment of psychoses although not in excited or manic patients. (From Martindale, The Extra Pharmacopoeia, 30th ed, p595) Emergil,Fluanxol,Flupentixol,alpha-Flupenthixol,cis-Flupenthixol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013892 Thioxanthenes Compounds with three aromatic rings in linear arrangement with a SULFUR in the center ring.

Related Publications

A E Balant-Gorgia, and L P Balant, and M Gex-Fabry, and C Genet
April 2024, Drug metabolism and disposition: the biological fate of chemicals,
A E Balant-Gorgia, and L P Balant, and M Gex-Fabry, and C Genet
July 1993, British journal of clinical pharmacology,
A E Balant-Gorgia, and L P Balant, and M Gex-Fabry, and C Genet
January 1983, Psychopharmacology,
A E Balant-Gorgia, and L P Balant, and M Gex-Fabry, and C Genet
July 1999, Psychopharmacology,
A E Balant-Gorgia, and L P Balant, and M Gex-Fabry, and C Genet
October 1975, British journal of clinical pharmacology,
A E Balant-Gorgia, and L P Balant, and M Gex-Fabry, and C Genet
November 1998, British journal of clinical pharmacology,
A E Balant-Gorgia, and L P Balant, and M Gex-Fabry, and C Genet
November 2020, Clinical pharmacology and therapeutics,
A E Balant-Gorgia, and L P Balant, and M Gex-Fabry, and C Genet
August 1974, European journal of clinical pharmacology,
Copied contents to your clipboard!